A single center, retrospective study of immune checkpoint inhibitors treatment in patients with metastatic melanoma and metastatic bladder cancer
Latest Information Update: 14 Apr 2020
At a glance
- Drugs Atezolizumab (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Bladder cancer; Malignant melanoma
- Focus Adverse reactions
Most Recent Events
- 14 Apr 2020 New trial record